Bizarre Patents
Process For Propelling Foodstuffs or the Like into a Crowd
A method of launching foodstuffs into a crowd for promotional and entertainment purposes.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7666996 | Casein derived peptides and uses thereof Biologically active peptides that are derived from or are similar to sequences identical with the N-terminus of the αS1 fraction of milk casein. These peptides are capable of stimulating and enhancing immune response, protecting against viral infection, normalizing... | 02/23/2010 |
| 7629442 | Acid soluble proteins from micellar casein The present invention relates to a milk fraction obtainable by acidification of micellar casein and separation from precipitated casein named acid soluble protein from micellar casein. It was found that the milk fraction and especially certain sub-fractions thereof ... | 12/08/2009 |
| 7312193 | Calcium phosphopeptide complexes Phosphopeptides containing the Ser(P) cluster sequence motif Ser(P)-Ser(P)-Ser(P)-Glu-Glu- can stabilize their own weight in amorphous calcium phosphate (ACP) [Ca3(PO4)1.87(HPO4)0.2xH2O] and amorphous... | 12/25/2007 |
| 7144855 | Protein complex from ion-exchange chromatography for treatment of bacterial infections The present invention relates to the use of alpha-lactalbumin in the preparation of preparations to be used in therapeutic or prophylactic treatment and/or for diagnostic use for infections, preferably of the respiratory tract, caused by bacteria, in particular S... | 12/05/2006 |
| 7129210 | Tissue adhesive sealant A tissue adhesive sealant includes a cross-linkable protein in a solution that when combined with a cross-linking agent solution including an aldehyde and amino acid containing species reactive with the aldehyde cross-links to form a seal. The sealant is well suited... | 10/31/2006 |
| 7122635 | Method and composition for angiogenesis inhibition The invention describes methods for inhibiting angiogenesis in a tissue by administering an antagonist that specifically binds to a proteolyzed or denatured collagen but not to native triple helical forms of the collagen. Antagonists of the invention can target, for... | 10/17/2006 |
| 7091320 | Product derived from milk substantially free of beta casein from non-human mammals and relative use The present invention is related to a product derived from milk, substantially free of beta casein from non-human mammals. The invention is also related to the use of such a product especially in relation to diet, more particularly for early infancy, in the preventi... | 08/15/2006 |
| 7015019 | 1-O-L-arginyl ester 3-O-monoacyl glycerides and 1-O-L-arginyl ester 2,3-O-diacyl glycerides type surface active agents This invention refers to new surface-active compounds derived from arginine of the mono and diacylglyceride type according to the general formula (I) designed to act as surface agents with antimicrobial activity. The variations in the activity will depend on the num... | 03/21/2006 |
| 6998143 | Ferric fortification system An iron fortification complex which may be used to fortify foods and beverages with iron. The complex is formed of ferric ions and caseinate. The complex is sufficiently stable as to be suitable for use in retorted products. However, despite the stability, the iron ... | 02/14/2006 |
| 6849593 | Bifidogenic peptides Pepetides having bifidogenic properties are obtainable by the process of adding proteases to cow'milk or human milk, followed by incubation, centrifugation, acidification, purification by reverse phase HPLC and cation-exchange HPLC, culturing Bifidobacterium bifi... | 02/01/2005 |
| 6838431 | Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety The invention relates to a nutritional intervention composition in powder form that is taken before a meal and that extends post meal satiety. The compositions of the invention are comprised of at least one protein, C12-18 fatty acids, preferably oleic ac... | 01/04/2005 |
| 6824783 | Methods for inhibition of membrane fusion-associated events, including HIV transmission The present invention relates to peptides which exhibit potent anti-retroviral activity. The peptides of the invention comprise DP178 (SEQ ID:1) peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homol... | 11/30/2004 |
| 6797810 | Method for isolation and modification of proteins A method for modification and isolation of a protein is provided. The method includes the steps of providing a protein selected from the group consisting of whey and soy proteins; providing a reagent that forms sulfite ions; mixing the protein with the reagent under... | 09/28/2004 |
| 6780844 | Calcium phosphopeptide complexes Phosphopeptides containing the Ser(P) cluster sequence motif Ser(P)-Ser(P)-Ser(P)-Glu-Glu- can stabilize their own weight in amorphous calcium phosphate (ACP) and amorphous calcium fluoride phosphate (ACFP). The amorphous phases stabilized by the phosphopeptides are... | 08/24/2004 |
| 6750203 | Product derived from milk substantially free of beta casein from non-human mammals and relative use The present invention is related to a product derived from milk, substantially free of beta casein from non-human mammals. The invention is also related to the use of such a product especially in relation to diet, more particularly for early infancy, in the preventi... | 06/15/2004 |
| 6656690 | Mass spectrometric methods for biomolecular screening The present invention provides methods for the determination of the structure of biomolecular targets, as well as the site and nature of the interaction between ligands and biomolecular targets. The present invention also provides methods for the determin... | 12/02/2003 |
| 6624144 | Matrix metalloproteinase inhibitors and down-regulators The present invention relates to novel matrix metalloproteinase (MMP) inhibitors and down-regulators, to a process for the preparation of these inhibitors, to pharmaceutical compositions comprising these inhibitors/down-regulators, to the use of the novel... | 09/23/2003 |
| 6599874 | Protein complex from ion-exchange chromatography of casein for treatment of bacterial infections Antibacterial protein complexes designated as Anti-adhesive Lactalbumin Like Protein (ALLP) are obtained by ion-exchange chromatography of casein and alpha-lactalbumin. Casein isolated from human milk by acid precipitation is subjected to ion-exchange chr... | 07/29/2003 |
| 6579849 | Antibiotic peptides from bovine milk A peptide having the amino acid sequence H2 N--X1 --R--X3 --X2 --COOH (formula I) wherein X1 is either zero or X1 and/or X2 are a residue representing at least five amino acid residues (s... | 06/17/2003 |
| 6558717 | Method for the sequential precipitation of casein and calcium phosphate from a milk source A method for isolating casein and calcium phosphate as separate products from a milk source, comprising the steps of: a) contacting the milk source with carbon dioxide under pressure in order to precipitate the casein; b) separating the casein from the mi... | 05/06/2003 |
| 6555659 | Process for isolating glycomacropeptide from dairy products with a phenylalanine impurity of 0.5% w/w The present invention is related to a method for the purification of glycomacropeptide (GMP) with an amino acid composition containing no greater that 0.5% (w/w) phenylalanine, comprising the steps of contacting a GMP-containing feedstock with a first ani... | 04/29/2003 |
| 6537760 | Receptor binding assay for detecting TSH-receptor auto-antibodies In a competitive receptor binding assay for detecting TSH-receptor auto-antibodies in a biological sample, the sample is reacted in a reaction mixture which contains (i) a TSH-receptor or TSH-receptor preparation; (ii) a primary competitor, for example la... | 03/25/2003 |
| 6521591 | Pharmaceutical composition for muscular anabolism A pharmaceutical composition suitable for enhancing muscular anabolism contains, per daily dose, at least 5 mg of anabolic initiators comprising anabolic growth factors, at least 0.12 g of protein equivalents of anabolic substrates and at least 3 g of ana... | 02/18/2003 |
| 6506732 | Enzymatic hydrolysate of milk proteins The present invention relates to a mixture of soluble hydrophobic peptides of an enzymatic hydrolysate of milk having skin hydrating properties and percutaneous absorption levels of 4 to 5%. The mixture also exhibits wound healing properties but does not ... | 01/14/2003 |
| 6495344 | Phenylalanine-free protein and DNA coding therefor A DNA molecule coding for a food protein, such as ovalbumin or casein, modified so that the codons for phenylalanine have been omitted or replaced by codons for one or more other metabolisable amino acids. Also a modified edible protein coded for by such ... | 12/17/2002 |
| 6462181 | Process for preparing a kappa-caseino glycomacropeptide or a derivative thereof Improved process for preparing a kappa-caseino glycomacropeptide which comprises adjusting the pH of a solution of a milk starting material to below 4, cold ultrafiltration and concentration of the starting material on a spiral filter. This process is usa... | 10/08/2002 |
| 6355612 | Protein material for slow digestion and its use The subject of the invention is the use of a protein material whose rate of digestion has been reduced, for the preparation of an enteral composition which makes it possible to modulate the postprandial plasma amino acid level, said protein material havin... | 03/12/2002 |
| 6270827 | Infant formula compositions and method of making Compositions containing human milk proteins, including the so-called host resistance factors of human milk, prepared by chemically synthesizing the human milk proteins or by genetic engineering techniques for producing recombinant human milk proteins, are... | 08/07/2001 |
| 6183754 | Anticytomegalovirus monoclonal antibodies and processes for the in vitro diagnosis of infections by human cytomegaloviruses and a protein-kinase inducible by cytomegaloviruses and recognizable by aforesaid monoclonal antibodies The invention relates to a process for in vitro diagnosis of an infection by human cytomegaloviruses. The process consists of contacting cells, possibly carrying the infection, with a monoclonal antibody reacting with a polypeptide of molecular weight 68,... | 02/06/2001 |
| 6180761 | Casein from Korean cattle A new casein is disclosed isolated from the milk of Korean cattle with a ଲ-casein A1 H genotype. Amino acid sequence analysis of the casein revealed a length of 209 amino acids, where, in comparison to the more conventional ଲ-casein... | 01/30/2001 |
| 6121421 | Methods for isolating recombinant ଲ-casein The invention provides a method for isolating a protein, specifically ଲ-casein, recombinantly produced in cells that have been genetically engineered to produce the protein. The method involves forming a paste, homogenate or lysate of the cells foll... | 09/19/2000 |
| 6107475 | Seven transmembrane receptors DNA sequences encoding seven novel seven transmembrane receptors and variants thereof are disclosed as well as materials and methods for production of the same by recombinant techniques. Antibody substances specific for each of the seven transmembrane rec... | 08/22/2000 |
| 6080844 | Process for the recovery and purification of a recombinant protein from a cell The present invention involves a process of purifying and recovering a recombinant protein from a suspension of cells. The process of the present invention involves extracting a recombinant protein from a concentrated suspension of cells using a water-mis... | 06/27/2000 |
| 6020015 | Infant formula compositions and nutrition containing genetically engineered human milk proteins Compositions containing human milk proteins, including the so-called host resistance factors of human milk, prepared by chemically synthesizing the human milk proteins or by genetic engineering techniques for producing recombinant human milk proteins, are... | 02/01/2000 |
| 5968901 | Antibacterial composition The present invention relates to a use of casein derived from milks, preferably human milk, and porcine milk, for the preparation of a substrate for the prophylactic and/or therapeutic treatment of infections of the respiratory tract caused by S. pneumoni... | 10/19/1999 |
| 5952009 | Methods for preventing the transmission of or treating patients infected with herpesvirus A method of preventing the transmission of or treating herpesvirus, such as herpes simplex virus infection, or Chlamydia trachomatis comprising administering to a patient a composition which comprises: (i) a protein or peptide containing lysines and an N-... | 09/14/1999 |
| 5942254 | Phosphorylated recombinant human ଲ-casein expressed in a bacterial system The present invention provides a plasmid containing a promoter sequence, a nucleotide sequence encoding an exogenous protein, and a nucleotide sequence encoding an enzyme capable of modifying the exogenous protein. In a specific embodiment of the inventio... | 08/24/1999 |
| 5852172 | Cold tolerances in plants A plurality of polypeptides derived from intercellular spaces of plant cells having frost tolerance. Some of the polypeptides are ice nucleators for developing ice crystals in extracellular spaces of plant tissue, some of the polypeptides are antifreeze c... | 12/22/1998 |
| 5843705 | Transgenically produced antithrombin III This invention relates to transgenically produced human Antithrombin III (tgATIII). The human ATIII produced by the transgenic process of the present invention has a monosaccharide composition which comprises N-acetylgalactosamine (GaINAc) along with fuco... | 12/01/1998 |
| 5834427 | Casein phosphopeptide, casein containing same and process for the preparation thereof The present invention relates to a purified casein phosphopeptide(CPP) having a novel amino acid sequence and a purified casein including same wherein the 25th Arg from N-terminal in a conventional CPP is replaced by Cys, rendering the CPPs to forming a d... | 11/10/1998 |
